Changes of immunological parameters with administration of Japanese Kampo medicine (Juzen-Taihoto/TJ-48) in patients with advanced pancreatic cancer
- 27 February 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Journal of Clinical Oncology
- Vol. 19 (1), 81-86
- https://doi.org/10.1007/s10147-013-0529-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Perceptions and attitudes of Japanese gynecologic cancer patients to Kampo (Japanese herbal) medicinesInternational Journal of Clinical Oncology, 2011
- Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic CancerAnnals of Surgical Oncology, 2010
- FOXP3+regulatory T cells as biomarkers in human malignanciesExpert Opinion on Biological Therapy, 2008
- Interferon-α Enhances Antitumor Effect of Chemotherapy in an Orthotopic Mouse Model for Pancreatic AdenocarcinomaJournal of Immunotherapy, 2008
- IL-12 and IL-18 Induction and Subsequent NKT Activation Effects of the Japanese Botanical Medicine JuzentaihotoInternational Journal of Molecular Sciences, 2008
- Prognostic factors for long-term survival in patients with locally invasive pancreatic cancerJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis CThe Esophagus, 2004
- A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancerSurgery, 2004
- Regulatory T cells in transplantation toleranceNature Reviews Immunology, 2003
- Treatment of Shwachman Syndrome by Japanese Herbal Medicine (Juzen‐Taiho‐To): Stimulatory Effects of Its Fatty Acids on Hemopoiesis in PatientsThe International Journal of Cell Cloning, 2002